{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:43Z","timestamp":1791273103524,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Peterbroeck Professorship Fund"},{"name":"Allard Janssen Fund"},{"DOI":"10.13039\/501100005042","name":"Cliniques Universitaires Saint-Luc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Involvement of the bone marrow by metastases from\u00a0solid tumors or multiple myeloma (MM) is a critical challenge in oncologic imaging. Lesion detection and staging, as well as accurate assessment of treatment response, disease recurrence, and complications, are key to optimal patient management. This article provides recommendations for performing and interpreting bone marrow MRI in cancer patients. MRI should be the primary imaging modality for patients suspected of having skeletal bone metastases or MM, and should replace radiography, bone scintigraphy, and CT for these indications. Protocols must be tailored to the clinical context and to each specific cancer. Whole-body MRI (WB-MRI) is preferred for a comprehensive assessment, while axial skeleton MRI (AS-MRI) is a fast and reliable alternative for targeted or follow-up evaluations. We recommend standardized protocols that incorporate anatomical sequences (preferably fast spin echo T2 Dixon) and diffusion-weighted imaging (DWI). Quantitative biomarkers, e.g., apparent diffusion coefficient (ADC) and fat fraction (FF), should be implemented to improve diagnostic accuracy and evaluate treatment response. Radiologists must be familiar with the typical patterns of bone marrow replacement by cancer cells, response assessment principles, and common imaging pitfalls. Every medical imaging facility should offer optimal bone marrow MRI and implement these recommendations using available MRI systems and existing disease-oriented guidelines. This ESR Essentials illustrates when, how, and why to perform bone marrow MRI to improve diagnostic precision and oncologic care across a broad range of indications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:italic>Prefer MRI of the bone marrow over radiographs, bone scintigraphy, or CT for suspected bone metastases of solid cancers and for myeloma staging<\/jats:italic>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:italic>Use MRI for diagnosis of bone involvement, disease staging, assessment of lesion response to treatment, detection of recurrence, and assessment of osseous complications<\/jats:italic>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:italic>Tailor MRI protocol to cancer type following existing guidelines, targeting either the axial skeleton or the \u201cwhole body,\u201d and using a panel of sequences with fat-sensitive, fast spin echo T2 Dixon and diffusion-weighted sequences as the fundamental components<\/jats:italic>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-12307-4","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:17:54Z","timestamp":1770661074000},"page":"5414-5428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ESR Essentials: bone marrow MRI in oncology\u2014practice recommendations by the European Society of Musculoskeletal Radiology"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-3254","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric E.","family":"Lecouvet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokmane","family":"Taihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kirchgesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Pasoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Halut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Tuba Sanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodoro","family":"Mart\u00edn-Noguerol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Vasilevska-Nikodinovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Vanhoenacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C.","family":"Vilanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"12307_CR1","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00330-010-1879-3","volume":"20","author":"FE Lecouvet","year":"2010","unstructured":"Lecouvet FE, Simon M, Tombal B, Jamart J, Vande Berg BC, Simoni P (2010) Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa). Eur Radiol 20:2973\u20132982. https:\/\/doi.org\/10.1007\/s00330-010-1879-3","journal-title":"Eur Radiol"},{"key":"12307_CR2","doi-asserted-by":"publisher","unstructured":"Ahlawat S, Debs P, Amini B, Lecouvet FE, Omoumi P, Wessell DE (2023) Clinical applications and controversies of whole-body MRI: AJR Expert Panel narrative review. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/ajr.22.28229","DOI":"10.2214\/ajr.22.28229"},{"key":"12307_CR3","doi-asserted-by":"publisher","first-page":"e210048","DOI":"10.1148\/rycan.2021210048","volume":"3","author":"C Messiou","year":"2021","unstructured":"Messiou C, Porta N, Sharma B et al (2021) Prospective evaluation of whole-body MRI versus FDG PET\/CT for lesion detection in participants with myeloma. Radiol Imaging Cancer 3:e210048. https:\/\/doi.org\/10.1148\/rycan.2021210048","journal-title":"Radiol Imaging Cancer"},{"key":"12307_CR4","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","volume":"21","author":"HL Yang","year":"2011","unstructured":"Yang HL, Liu T, Wang XM, Xu Y, Deng SM (2011) Diagnosis of bone metastases: a meta-analysis comparing \u00b9\u2078FDG PET, CT, MRI and bone scintigraphy. Eur Radiol 21:2604\u20132617. https:\/\/doi.org\/10.1007\/s00330-011-2221-4","journal-title":"Eur Radiol"},{"key":"12307_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/pros.20280","volume":"65","author":"B Tombal","year":"2005","unstructured":"Tombal B, Rezazadeh A, Therasse P, Van Cangh PJ, Vande Berg B, Lecouvet FE (2005) Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases. Prostate 65:178\u2013187. https:\/\/doi.org\/10.1002\/pros.20280","journal-title":"Prostate"},{"key":"12307_CR6","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00256-024-04723-2","volume":"53","author":"FE Lecouvet","year":"2024","unstructured":"Lecouvet FE, Chabot C, Taihi L, Kirchgesner T, Triqueneaux P, Malghem J (2024) Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it. Skelet Radiol 53:1815\u20131831. https:\/\/doi.org\/10.1007\/s00256-024-04723-2","journal-title":"Skelet Radiol"},{"key":"12307_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00330-014-3114-0","volume":"24","author":"AS Littooij","year":"2014","unstructured":"Littooij AS, Kwee TC, Barber I et al (2014) Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET\/CT-based reference standard. Eur Radiol 24:1153\u20131165. https:\/\/doi.org\/10.1007\/s00330-014-3114-0","journal-title":"Eur Radiol"},{"key":"12307_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.eururo.2012.02.020","volume":"62","author":"FE Lecouvet","year":"2012","unstructured":"Lecouvet FE, El Mouedden J, Collette L et al (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62:68\u201375. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.020","journal-title":"Eur Urol"},{"key":"12307_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/0284186x.2015.1027411","volume":"55","author":"I Jambor","year":"2016","unstructured":"Jambor I, Kuisma A, Ramadan S et al (2016) Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol 55:59\u201367. https:\/\/doi.org\/10.3109\/0284186x.2015.1027411","journal-title":"Acta Oncol"},{"key":"12307_CR10","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jmri.25726","volume":"46","author":"Y Ohno","year":"2017","unstructured":"Ohno Y, Yoshikawa T, Kishida Y et al (2017) Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer. J Magn Reson Imaging 46:1707\u20131717. https:\/\/doi.org\/10.1002\/jmri.25726","journal-title":"J Magn Reson Imaging"},{"key":"12307_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s2468-1253(19)30056-1","volume":"4","author":"SA Taylor","year":"2019","unstructured":"Taylor SA, Mallett S, Beare S et al (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. Lancet Gastroenterol Hepatol 4:529\u2013537. https:\/\/doi.org\/10.1016\/s2468-1253(19)30056-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"12307_CR12","doi-asserted-by":"publisher","unstructured":"Noebauer-Huhmann IM, Vanhoenacker FM, Vilanova JC et al (2024) Soft tissue tumor imaging in adults: whole-body staging in sarcoma, non-malignant entities requiring special algorithms, pitfalls and special imaging aspects. Guidelines 2024 from the European Society of Musculoskeletal Radiology (ESSR). Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-10897-z10.1007\/s00330-024-10897-z","DOI":"10.1007\/s00330-024-10897-z10.1007\/s00330-024-10897-z"},{"key":"12307_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1102\/1470-7330.2013.0007","volume":"13","author":"C Schraml","year":"2013","unstructured":"Schraml C, Schwenzer NF, Sperling O et al (2013) Staging of neuroendocrine tumours: comparison of [\u2076\u2078Ga]DOTATOC multiphase PET\/CT and whole-body MRI. Cancer Imaging 13:63\u201372. https:\/\/doi.org\/10.1102\/1470-7330.2013.0007","journal-title":"Cancer Imaging"},{"key":"12307_CR14","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1007\/s00330-019-06132-9","volume":"29","author":"S Kalus","year":"2019","unstructured":"Kalus S, Saifuddin A (2019) Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review. Eur Radiol 29:5700\u20135708. https:\/\/doi.org\/10.1007\/s00330-019-06132-9","journal-title":"Eur Radiol"},{"key":"12307_CR15","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1007\/s00259-020-05182-2","volume":"48","author":"O Westerland","year":"2021","unstructured":"Westerland O, Amlani A, Kelly-Morland C et al (2021) Comparison of the diagnostic performance and impact on management of 18F-FDG PET\/CT and whole-body MRI in multiple myeloma. Eur J Nucl Med Mol Imaging 48:2558\u20132565. https:\/\/doi.org\/10.1007\/s00259-020-05182-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12307_CR16","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/jco.2009.25.5356","volume":"28","author":"J Hillengass","year":"2010","unstructured":"Hillengass J, Fechtner K, Weber MA et al (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 28:1606\u20131610. https:\/\/doi.org\/10.1200\/jco.2009.25.5356","journal-title":"J Clin Oncol"},{"key":"12307_CR17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3324\/haematol.2012.065359","volume":"97","author":"J Hillengass","year":"2012","unstructured":"Hillengass J, Ayyaz S, Kilk K et al (2012) Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma. Haematologica 97:1757\u20131760. https:\/\/doi.org\/10.3324\/haematol.2012.065359","journal-title":"Haematologica"},{"key":"12307_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1148\/radiology.168.3.3043546","volume":"168","author":"JB Vogler 3rd","year":"1988","unstructured":"Vogler JB 3rd, Murphy WA (1988) Bone marrow imaging. Radiology 168:679\u2013693. https:\/\/doi.org\/10.1148\/radiology.168.3.3043546","journal-title":"Radiology"},{"key":"12307_CR19","doi-asserted-by":"publisher","unstructured":"Omoumi P (2021) The Dixon method in musculoskeletal MRI: from fat-sensitive to fat-specific imaging. Skelet Radiol. https:\/\/doi.org\/10.1007\/s00256-021-03950-110.1007\/s00256-021-03950-1","DOI":"10.1007\/s00256-021-03950-110.1007\/s00256-021-03950-1"},{"key":"12307_CR20","doi-asserted-by":"publisher","unstructured":"Omoumi P, Mourad C, Rapacchi S, Pastor M (2026) How i do it: using the Dixon method and fat-water imaging in musculoskeletal MRI. Radiology https:\/\/doi.org\/10.1148\/radiol.250374","DOI":"10.1148\/radiol.250374"},{"key":"12307_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.diii.2019.05.001","volume":"100","author":"A Danner","year":"2019","unstructured":"Danner A, Brumpt E, Alilet M, Tio G, Omoumi P, Aubry S (2019) Improved contrast for myeloma focal lesions with T2-weighted Dixon images compared to T1-weighted images. Diagn Interv Imaging 100:513\u2013519. https:\/\/doi.org\/10.1016\/j.diii.2019.05.001","journal-title":"Diagn Interv Imaging"},{"key":"12307_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1055\/s-0035-1565913","volume":"19","author":"H Guerini","year":"2015","unstructured":"Guerini H, Omoumi P, Guichoux F et al (2015) Fat suppression with Dixon techniques in musculoskeletal magnetic resonance imaging: a pictorial review. Semin Musculoskelet Radiol 19:335\u2013347. https:\/\/doi.org\/10.1055\/s-0035-1565913","journal-title":"Semin Musculoskelet Radiol"},{"key":"12307_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s41747-025-00615-9","volume":"9","author":"MI Metwally","year":"2025","unstructured":"Metwally MI, Almalki YE, Khalil MF et al (2025) Quantitative MRI Dixon signal drop and fat fraction for differentiating bone marrow lesions: a two-center prospective analysis. Eur Radiol Exp 9:89. https:\/\/doi.org\/10.1186\/s41747-025-00615-9","journal-title":"Eur Radiol Exp"},{"key":"12307_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00330-015-3898-6","volume":"26","author":"H Douis","year":"2016","unstructured":"Douis H, Davies AM, Jeys L, Sian P (2016) Chemical shift MRI can aid in the diagnosis of indeterminate skeletal lesions of the spine. Eur Radiol 26:932\u2013940. https:\/\/doi.org\/10.1007\/s00330-015-3898-6","journal-title":"Eur Radiol"},{"key":"12307_CR25","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00256-019-03271-4","volume":"48","author":"N van Vucht","year":"2019","unstructured":"van Vucht N, Santiago R, Lottmann B et al (2019) The Dixon technique for MRI of the bone marrow. Skelet Radiol 48:1861\u20131874. https:\/\/doi.org\/10.1007\/s00256-019-03271-4","journal-title":"Skelet Radiol"},{"key":"12307_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00330-022-09007-8","volume":"33","author":"O Chiabai","year":"2023","unstructured":"Chiabai O, Van Nieuwenhove S, Vekemans MC et al (2023) Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma? Eur Radiol 33:244\u2013257. https:\/\/doi.org\/10.1007\/s00330-022-09007-8","journal-title":"Eur Radiol"},{"key":"12307_CR27","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00330-011-2116-4","volume":"21","author":"C Messiou","year":"2011","unstructured":"Messiou C, Collins DJ, Morgan VA, Desouza NM (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol 21:1713\u20131718. https:\/\/doi.org\/10.1007\/s00330-011-2116-4","journal-title":"Eur Radiol"},{"key":"12307_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00256-021-03841-5","volume":"51","author":"FE Lecouvet","year":"2022","unstructured":"Lecouvet FE, Vekemans MC, Van Den Berghe T et al (2022) Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET\/CT. Skelet Radiol 51:59\u201380. https:\/\/doi.org\/10.1007\/s00256-021-03841-5","journal-title":"Skelet Radiol"},{"key":"12307_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/RLI.0000000000000415","volume":"53","author":"R Perez-Lopez","year":"2018","unstructured":"Perez-Lopez R, Nava Rodrigues D, Figueiredo I et al (2018) Multiparametric magnetic resonance imaging of prostate cancer bone disease: correlation with bone biopsy histological and molecular features. Invest Radiol 53:96\u2013102. https:\/\/doi.org\/10.1097\/RLI.0000000000000415","journal-title":"Invest Radiol"},{"key":"12307_CR30","doi-asserted-by":"publisher","first-page":"20170389","DOI":"10.1259\/bjr.20170389","volume":"91","author":"V Koutoulidis","year":"2018","unstructured":"Koutoulidis V, Papanikolaou N, Moulopoulos LA (2018) Functional and molecular MRI of the bone marrow in multiple myeloma. Br J Radiol 91:20170389. https:\/\/doi.org\/10.1259\/bjr.20170389","journal-title":"Br J Radiol"},{"key":"12307_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1148\/radiol.2522081756","volume":"252","author":"T Bauerle","year":"2009","unstructured":"Bauerle T, Hillengass J, Fechtner K et al (2009) Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging. Radiology 252:477\u2013485. https:\/\/doi.org\/10.1148\/radiol.2522081756","journal-title":"Radiology"},{"key":"12307_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1148\/radiol.2017170325","volume":"286","author":"Y Maeder","year":"2018","unstructured":"Maeder Y, Dunet V, Richard R, Becce F, Omoumi P (2018) Bone marrow metastases: T2-weighted Dixon spin-echo fat images can replace T1-weighted spin-echo images. Radiology 286:948\u2013959. https:\/\/doi.org\/10.1148\/radiol.2017170325","journal-title":"Radiology"},{"key":"12307_CR33","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s00330-019-06515-y","volume":"30","author":"FE Lecouvet","year":"2020","unstructured":"Lecouvet FE, Pasoglou V, Van Nieuwenhove S et al (2020) Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer. Eur Radiol 30:3083\u20133093. https:\/\/doi.org\/10.1007\/s00330-019-06515-y","journal-title":"Eur Radiol"},{"key":"12307_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","volume":"71","author":"AR Padhani","year":"2017","unstructured":"Padhani AR, Lecouvet FE, Tunariu N et al (2017) Metastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71:81\u201392. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.033","journal-title":"Eur Urol"},{"key":"12307_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S et al (2019) Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS). Radiology 291:5\u201313. https:\/\/doi.org\/10.1148\/radiol.2019181949","journal-title":"Radiology"},{"key":"12307_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1148\/radiol.14141242","volume":"275","author":"V Pasoglou","year":"2015","unstructured":"Pasoglou V, Michoux N, Peeters F et al (2015) Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease. Radiology 275:155\u2013166. https:\/\/doi.org\/10.1148\/radiol.14141242","journal-title":"Radiology"},{"key":"12307_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1148\/radiology.204.1.9205247","volume":"204","author":"FE Lecouvet","year":"1997","unstructured":"Lecouvet FE, Malghem J, Michaux L et al (1997) Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 204:201\u2013205. https:\/\/doi.org\/10.1148\/radiology.204.1.9205247","journal-title":"Radiology"},{"key":"12307_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1148\/radiology.188.1.8511306","volume":"188","author":"ME Schweitzer","year":"1993","unstructured":"Schweitzer ME, Levine C, Mitchell DG, Gannon FH, Gomella LG (1993) Bull\u2019s-eyes and halos: useful MR discriminators of osseous metastases. Radiology 188:249\u2013252. https:\/\/doi.org\/10.1148\/radiology.188.1.8511306","journal-title":"Radiology"},{"key":"12307_CR39","doi-asserted-by":"publisher","first-page":"20200206","DOI":"10.1259\/bjr.20200206","volume":"93","author":"R Rajakulasingam","year":"2020","unstructured":"Rajakulasingam R, Saifuddin A (2020) Focal nodular marrow hyperplasia: imaging features of 53 cases. Br J Radiol 93:20200206. https:\/\/doi.org\/10.1259\/bjr.20200206","journal-title":"Br J Radiol"},{"key":"12307_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00256-019-03257-2","volume":"49","author":"JM Hoyle","year":"2020","unstructured":"Hoyle JM, Layfield LJ, Crim J (2020) The lipid-poor hemangioma: an investigation into the behavior of the \u201catypical\u201d hemangioma. Skelet Radiol 49:93\u2013100. https:\/\/doi.org\/10.1007\/s00256-019-03257-2","journal-title":"Skelet Radiol"},{"key":"12307_CR41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00330-017-5079-2","volume":"28","author":"JM Winfield","year":"2018","unstructured":"Winfield JM, Poillucci G, Blackledge MD et al (2018) Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI. Eur Radiol 28:1687\u20131691. https:\/\/doi.org\/10.1007\/s00330-017-5079-2","journal-title":"Eur Radiol"},{"key":"12307_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00256-007-0435-y","volume":"37","author":"T Yamaguchi","year":"2008","unstructured":"Yamaguchi T, Iwata J, Sugihara S et al (2008) Distinguishing benign notochordal cell tumors from vertebral chordoma. Skelet Radiol 37:291\u2013299. https:\/\/doi.org\/10.1007\/s00256-007-0435-y","journal-title":"Skelet Radiol"},{"key":"12307_CR43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.rcl.2005.01.007","volume":"43","author":"BC Vande Berg","year":"2005","unstructured":"Vande Berg BC, Lecouvet FE, Galant C, Maldague BE, Malghem J (2005) Normal variants and frequent marrow alterations that simulate bone marrow lesions at MR imaging. Radiol Clin North Am 43:761\u2013770. https:\/\/doi.org\/10.1016\/j.rcl.2005.01.007","journal-title":"Radiol Clin North Am"},{"key":"12307_CR44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1148\/radiology.189.3.7694312","volume":"189","author":"BD Fletcher","year":"1993","unstructured":"Fletcher BD, Wall JE, Hanna SL (1993) Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy. Radiology 189:745\u2013751. https:\/\/doi.org\/10.1148\/radiology.189.3.7694312","journal-title":"Radiology"},{"key":"12307_CR45","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2214\/ajr.11.7866","volume":"199","author":"DM Koh","year":"2012","unstructured":"Koh DM, Blackledge M, Padhani AR et al (2012) Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 199:252\u2013262. https:\/\/doi.org\/10.2214\/ajr.11.7866","journal-title":"AJR Am J Roentgenol"},{"key":"12307_CR46","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s00330-013-2792-3","volume":"23","author":"FE Lecouvet","year":"2013","unstructured":"Lecouvet FE, Larbi A, Pasoglou V et al (2013) MRI for response assessment in metastatic bone disease. Eur Radiol 23:1986\u20131997. https:\/\/doi.org\/10.1007\/s00330-013-2792-3","journal-title":"Eur Radiol"},{"key":"12307_CR47","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/jmri.24548","volume":"39","author":"AR Padhani","year":"2014","unstructured":"Padhani AR, Makris A, Gall P, Collins DJ, Tunariu N, de Bono JS (2014) Therapy monitoring of skeletal metastases with whole-body diffusion MRI. J Magn Reson Imaging 39:1049\u20131078. https:\/\/doi.org\/10.1002\/jmri.24548","journal-title":"J Magn Reson Imaging"},{"key":"12307_CR48","doi-asserted-by":"publisher","unstructured":"Esperan\u00e7a-Martins M, Roque D, Barroso T et al (2023) Multidisciplinary approach to spinal metastases and metastatic spinal cord compression\u2014a new integrative flowchart for patient management. Cancers. (Basel) https:\/\/doi.org\/10.3390\/cancers15061796","DOI":"10.3390\/cancers15061796"},{"key":"12307_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jmri.1880060416","volume":"6","author":"LA Moulopoulos","year":"1996","unstructured":"Moulopoulos LA, Yoshimitsu K, Johnston DA, Leeds NE, Libshitz HI (1996) MR prediction of benign and malignant vertebral compression fractures. J Magn Reson Imaging 6:667\u2013674. https:\/\/doi.org\/10.1002\/jmri.1880060416","journal-title":"J Magn Reson Imaging"},{"key":"12307_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00330-006-0404-1","volume":"17","author":"HE Daldrup-Link","year":"2007","unstructured":"Daldrup-Link HE, Henning T, Link TM (2007) MR imaging of therapy-induced changes of bone marrow. Eur Radiol 17:743\u2013761. https:\/\/doi.org\/10.1007\/s00330-006-0404-1","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12307-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:17:48Z","timestamp":1781864268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12307-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["12307"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12307-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Fr\u00e9d\u00e9ric Lecouvet.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare relationships with the following companies: Fr\u00e9d\u00e9ric E. Lecouvet has a Research collaboration\/grants with GE HealthCare. The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}